Tag Archives: United States district court

AZ Celebrates Crestor Patent Win

By George Koroneos | Published: June 30, 2010

The US District Court in Delaware upheld AstraZeneca’s patent for its blockbuster statin Crestor (rosuvastatin), ending a dispute that could have crippled the drugmaker’s billion-dollar cash cow. Crestor’s patent is not scheduled to expire until 2016. However, a group of generics firms had claimed that a substance patent (314) protecting one of the active ingredients in [...]

Posted in Legal | Also tagged AstraZeneca, David Brennan, Intellectual property, Legal burden of proof, pharmaceutical industry, Shionogi, United States Patent and Trademark Office | Leave a comment

Judge Spikes Myriad Genetic’s Control of Genes

By George Koroneos | Published: March 30, 2010

Image via Wikipedia Score one for nature. A US district court judge on Monday declared that pharma companies can’t patent individual genes because they are they are not, in fact, creating them. Last spring, Myriad Genetics was taken to task by the ACLU for monopolizing a patent it had discovered for breast cancer. The civil rights group [...]

Posted in Biotech, News | Also tagged American Civil Liberties Union, Breast cancer, Gene patent, Intellectual property, Myriad Genetics, Patent, Peter Meldrum | 1 Comment